Shufro Rose & Co. LLC Trims Stake in Hanesbrands Inc. (HBI)

Share on StockTwits

Shufro Rose & Co. LLC lessened its stake in shares of Hanesbrands Inc. (NYSE:HBI) by 28.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 286,848 shares of the textile maker’s stock after selling 114,019 shares during the period. Shufro Rose & Co. LLC owned about 0.08% of Hanesbrands worth $5,287,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in HBI. Truvestments Capital LLC bought a new stake in Hanesbrands in the third quarter valued at approximately $129,000. WP Advisors LLC acquired a new position in shares of Hanesbrands in the second quarter valued at approximately $145,000. Amica Retiree Medical Trust grew its position in shares of Hanesbrands by 180.3% in the second quarter. Amica Retiree Medical Trust now owns 7,296 shares of the textile maker’s stock valued at $161,000 after purchasing an additional 4,693 shares during the last quarter. First Capital Advisors Group LLC. acquired a new position in shares of Hanesbrands in the third quarter valued at approximately $185,000. Finally, Advisory Services Network LLC grew its position in shares of Hanesbrands by 124.7% in the second quarter. Advisory Services Network LLC now owns 8,503 shares of the textile maker’s stock valued at $187,000 after purchasing an additional 4,719 shares during the last quarter. Institutional investors and hedge funds own 99.58% of the company’s stock.

HBI has been the topic of several research reports. Barclays set a $18.00 target price on Hanesbrands and gave the company a “hold” rating in a research report on Thursday, November 1st. Macquarie decreased their target price on Hanesbrands from $15.00 to $14.00 and set a “hold” rating on the stock in a research report on Thursday, August 23rd. Bank of America decreased their target price on Hanesbrands from $20.00 to $18.00 and set a “neutral” rating on the stock in a research report on Friday, November 2nd. Standpoint Research started coverage on Hanesbrands in a research report on Tuesday, October 23rd. They issued a “buy” rating and a $20.00 target price on the stock. Finally, Buckingham Research reduced their price target on Hanesbrands from $26.00 to $24.00 and set a “buy” rating on the stock in a research report on Wednesday, October 17th. One analyst has rated the stock with a sell rating, nine have given a hold rating and six have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus target price of $21.67.

Shares of HBI stock opened at $14.91 on Friday. The firm has a market capitalization of $5.38 billion, a price-to-earnings ratio of 7.73, a price-to-earnings-growth ratio of 0.86 and a beta of 0.39. Hanesbrands Inc. has a fifty-two week low of $14.83 and a fifty-two week high of $23.33. The company has a debt-to-equity ratio of 4.44, a quick ratio of 0.79 and a current ratio of 1.84.

Hanesbrands (NYSE:HBI) last issued its earnings results on Thursday, November 1st. The textile maker reported $0.55 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.55. Hanesbrands had a return on equity of 85.49% and a net margin of 0.10%. The firm had revenue of $1.85 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter last year, the business posted $0.60 EPS. The company’s revenue was up 2.7% compared to the same quarter last year. On average, analysts forecast that Hanesbrands Inc. will post 1.73 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 4th. Stockholders of record on Tuesday, November 13th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 4.02%. The ex-dividend date is Friday, November 9th. Hanesbrands’s payout ratio is 31.09%.

In related news, Director Ronald L. Nelson bought 25,000 shares of the stock in a transaction that occurred on Friday, November 2nd. The stock was acquired at an average cost of $15.95 per share, with a total value of $398,750.00. Following the transaction, the director now directly owns 131,683 shares in the company, valued at $2,100,343.85. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Jessica Tuchman Mathews sold 2,115 shares of the firm’s stock in a transaction on Monday, November 12th. The stock was sold at an average price of $16.54, for a total value of $34,982.10. Following the transaction, the director now directly owns 132,129 shares of the company’s stock, valued at $2,185,413.66. The disclosure for this sale can be found here. 1.06% of the stock is currently owned by corporate insiders.

ILLEGAL ACTIVITY WARNING: This story was first published by BBNS and is owned by of BBNS. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://baseballnewssource.com/2018/11/18/shufro-rose-co-llc-has-5-29-million-stake-in-hanesbrands-inc-hbi-2/2886964.html.

About Hanesbrands

Hanesbrands Inc, a consumer goods company, designs, manufactures, sources, and sells a range of basic apparel for men, women, and children in the United States. The company operates through three segments: Innerwear, Activewear, and International. It sells bras, panties, men's underwear, children's underwear, activewear, socks, hosiery, intimate apparel, shapewears, and home goods; and T-shirts, fleece, sport shirts, performance T-shirts and shorts, sports bras, and thermals, as well as licensed logo apparel in collegiate bookstores, mass retailers, and other channels.

Read More: What is the Dow Jones Industrial Average (DJIA)?

Institutional Ownership by Quarter for Hanesbrands (NYSE:HBI)

Receive News & Ratings for Hanesbrands Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hanesbrands and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.